Skip to content

Clinical trials

Enrolling by invitation Genetic Diseases, Inborn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Status: Enrolling by invitation Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20192
20201
20214
20231
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company3
TESS Research Foundation2
Vertex Pharmaceuticals Incorporated2
BioMarin Pharmaceutical1
Editas Medicine, Inc.1
Jerry Vockley, MD, PhD1
Karolinska Institutet1
Massachusetts General Hospital1
Mayo Clinic1
Rady Pediatric Genomics & Systems Medicine Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn17
Musculoskeletal Diseases4
Rare Diseases4
Bone Diseases3
Hematologic Diseases3
Mucopolysaccharidosis IV3
Osteochondrodysplasias3
Anemia, Sickle Cell2
Dwarfism2
Epilepsy2

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.